Charcot-Marie-Tooth Disease Type 4J and Multiple Sclerosis

J Clin Neuromuscul Dis. 2019 Dec;21(2):117-118. doi: 10.1097/CND.0000000000000258.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Age of Onset
  • Anti-Inflammatory Agents / therapeutic use
  • Charcot-Marie-Tooth Disease / complications*
  • Charcot-Marie-Tooth Disease / genetics
  • Disease Progression
  • Flavoproteins / genetics
  • Humans
  • Male
  • Multiple Sclerosis / complications*
  • Multiple Sclerosis / genetics
  • Neurologic Examination
  • Pedigree
  • Phosphoric Monoester Hydrolases / genetics
  • Steroids / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Flavoproteins
  • Steroids
  • FIG4 protein, human
  • Phosphoric Monoester Hydrolases

Supplementary concepts

  • Charcot-Marie-Tooth Disease, Type 4j